(Q33978114)

30 July 2017

In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. (English)

1 reference

30 July 2017

0 references

D J Kenny

1

1 reference

30 July 2017

P Russell

2

1 reference

30 July 2017

D Rogers

3

1 reference

30 July 2017

S M Eley

4

1 reference

30 July 2017

R W Titball

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

1 reference

30 July 2017

43

1 reference

30 July 2017

11

1 reference

30 July 2017

2773-2775

1 reference

Oral fluoroquinolones for maintenance treatment of melioidosis

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

Intracellular survival of Burkholderia pseudomallei

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

The Pseudomallei Group: A Review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

In vitro susceptibility of Pseudomonas mallei to antimicrobial agents.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

Halving of mortality of severe melioidosis by ceftazidime

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

[Sensitivity of Pseudomonas to currently used antibacterial drugs].

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

Melioidosis: the tip of the iceberg?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

Pulmonary melioidosis. Observations in thirty-nine cases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89557

[Treatment of experimental glanders with combinations of sulfazine or sulfamonomethoxine with trimethoprim]

5 July 2018

1 reference

12 December 2020

[The efficacy of antibacterial preparations against Pseudomonas mallei in in-vitro and in-vivo experiments]

1 reference

12 December 2020

[Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders]

1 reference

12 December 2020

In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei

1 reference

12 December 2020

Identifiers

PMCID

89557

1 reference

30 July 2017

1 reference